List of Ranbaxy Laboratories patents

Patents where

Current Assignee

Name

Ranbaxy Laboratories

Name	Description	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7501443 Flavaxate derivatives as muscarinic receptor antagonists	Patent 7501443 was granted and assigned to Ranbaxy Laboratories on March, 2009 by the United States Patent and Trademark Office.	Ranbaxy Laboratories	United States Patent and Trademark Office	7501443	March 10, 2009
‌ US Patent 7288562 Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo (3.1.0) hexane derivatives as muscarinic receptor antagonists	Patent 7288562 was granted and assigned to Ranbaxy Laboratories on October, 2007 by the United States Patent and Trademark Office.	Ranbaxy Laboratories	United States Patent and Trademark Office	7288562	October 30, 2007
‌ US Patent 7410993 3,6-disubstituted azabicyclo [3.1.0] hexane deriviatives useful as muscarinic receptor antagonists	Patent 7410993 was granted and assigned to Ranbaxy Laboratories on August, 2008 by the United States Patent and Trademark Office.	Ranbaxy Laboratories	United States Patent and Trademark Office	7410993	August 12, 2008
‌ US Patent 7265147 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists	Patent 7265147 was granted and assigned to Ranbaxy Laboratories on September, 2007 by the United States Patent and Trademark Office.	Ranbaxy Laboratories	United States Patent and Trademark Office	7265147	September 4, 2007
‌ US Patent 7592359 Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists	Patent 7592359 was granted and assigned to Ranbaxy Laboratories on September, 2009 by the United States Patent and Trademark Office.	Ranbaxy Laboratories	United States Patent and Trademark Office	7592359	September 22, 2009
‌ US Patent 7517905 Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists	Patent 7517905 was granted and assigned to Ranbaxy Laboratories on April, 2009 by the United States Patent and Trademark Office.	Ranbaxy Laboratories	United States Patent and Trademark Office	7517905	April 14, 2009
‌ US Patent 7488748 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists	Patent 7488748 was granted and assigned to Ranbaxy Laboratories on February, 2009 by the United States Patent and Trademark Office.	Ranbaxy Laboratories	United States Patent and Trademark Office	7488748	February 10, 2009
‌ US Patent 7399779 3,6-disubstituted azabicyclo [3.1.0] hexane derivatives useful as muscarinic receptor antagonists	Patent 7399779 was granted and assigned to Ranbaxy Laboratories on July, 2008 by the United States Patent and Trademark Office.	Ranbaxy Laboratories	United States Patent and Trademark Office	7399779	July 15, 2008
‌ US Patent 7232835 3,6-Disubstituted azabicyclo derivatives as muscarinic receptor antagonists	Patent 7232835 was granted and assigned to Ranbaxy Laboratories on June, 2007 by the United States Patent and Trademark Office.	Ranbaxy Laboratories	United States Patent and Trademark Office	7232835	June 19, 2007
‌ US Patent 7115281 Processes for the preparation of oral dosage formulations of modafinil	Patent 7115281 was granted and assigned to Ranbaxy Laboratories on October, 2006 by the United States Patent and Trademark Office.	Ranbaxy Laboratories	United States Patent and Trademark Office	7115281	October 3, 2006
‌ US Patent 7446123 Azabicyclo derivatives as muscarinic receptor antagonists	Patent 7446123 was granted and assigned to Ranbaxy Laboratories on November, 2008 by the United States Patent and Trademark Office.	Ranbaxy Laboratories	United States Patent and Trademark Office	7446123	November 4, 2008
‌ US Patent 7332600 Process for the preparation of crystalline imipenem	Patent 7332600 was granted and assigned to Ranbaxy Laboratories on February, 2008 by the United States Patent and Trademark Office.	Ranbaxy Laboratories	United States Patent and Trademark Office	7332600	February 19, 2008
‌ US Patent 7560479 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists	Patent 7560479 was granted and assigned to Ranbaxy Laboratories on July, 2009 by the United States Patent and Trademark Office.	Ranbaxy Laboratories	United States Patent and Trademark Office	7560479	July 14, 2009
‌ US Patent 7566782 Process for the preparation of rosuvastatin	Patent 7566782 was granted and assigned to Ranbaxy Laboratories on July, 2009 by the United States Patent and Trademark Office.	Ranbaxy Laboratories	United States Patent and Trademark Office	7566782	July 28, 2009
‌ US Patent 7241885 Process for the isolation of crystalline imipenem	Patent 7241885 was granted and assigned to Ranbaxy Laboratories on July, 2007 by the United States Patent and Trademark Office.	Ranbaxy Laboratories	United States Patent and Trademark Office	7241885	July 10, 2007
‌ US Patent 7465751 1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists	Patent 7465751 was granted and assigned to Ranbaxy Laboratories on December, 2008 by the United States Patent and Trademark Office.	Ranbaxy Laboratories	United States Patent and Trademark Office	7465751	December 16, 2008
‌ US Patent 7482463 Amorphous form of esomeprazole salts	Patent 7482463 was granted and assigned to Ranbaxy Laboratories on January, 2009 by the United States Patent and Trademark Office.	Ranbaxy Laboratories	United States Patent and Trademark Office	7482463	January 27, 2009
‌ US Patent 7462712 Process for the preparation of imipenem	Patent 7462712 was granted and assigned to Ranbaxy Laboratories on December, 2008 by the United States Patent and Trademark Office.	Ranbaxy Laboratories	United States Patent and Trademark Office	7462712	December 9, 2008
‌ US Patent 7592335 Oxazolidinone derivatives as antimicrobials	Patent 7592335 was granted and assigned to Ranbaxy Laboratories on September, 2009 by the United States Patent and Trademark Office.	Ranbaxy Laboratories	United States Patent and Trademark Office	7592335	September 22, 2009
‌ US Patent 7148355 Process for the preparation of repaglinide	Patent 7148355 was granted and assigned to Ranbaxy Laboratories on December, 2006 by the United States Patent and Trademark Office.	Ranbaxy Laboratories	United States Patent and Trademark Office	7148355	December 12, 2006
‌ US Patent 7045618 Cefpodixime proxetil	Patent 7045618 was granted and assigned to Ranbaxy Laboratories on May, 2006 by the United States Patent and Trademark Office.	Ranbaxy Laboratories	United States Patent and Trademark Office	7045618	May 16, 2006
‌ US Patent 7078524 Process for the synthesis of ganciclovir	Patent 7078524 was granted and assigned to Ranbaxy Laboratories on July, 2006 by the United States Patent and Trademark Office.	Ranbaxy Laboratories	United States Patent and Trademark Office	7078524	July 18, 2006
‌ US Patent 7078430 HMG CoA-reductase inhibitors	Patent 7078430 was granted and assigned to Ranbaxy Laboratories on July, 2006 by the United States Patent and Trademark Office.	Ranbaxy Laboratories	United States Patent and Trademark Office	7078430	July 18, 2006
‌ US Patent 7078534 Process for the preparation of crystalline N-formimidoyl thienamycin monohydrate (imipenem monohydrate)	Patent 7078534 was granted and assigned to Ranbaxy Laboratories on July, 2006 by the United States Patent and Trademark Office.	Ranbaxy Laboratories	United States Patent and Trademark Office	7078534	July 18, 2006

24 results

0 selected

24 results

0 selected